EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
This publication considers the potential implications of IFRS 15 Revenue from Contracts with Customers for life sciences entities.
Life sciences entities may need to use significant judgement and make more estimates under IFRS 15 Revenue from Contracts with Customers 19than they do under legacy IFRS. Life sciences entities have to update their policies, systems and controls to meet the new requirements, although their pattern of revenue recognition may not change. The standard also requires greater disclosure. This publication highlights key aspects of applying the standard to life sciences arrangements, addresses significant changes to legacy practice and reflects the latest implementation insights.